Fifth Third Bancorp
EVMN

Fifth Third Bancorp’s Evommune Inc EVMN Stock Holding History

Fifth Third Bancorp’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273 Hold
21
– – ﹤0.01% 4276
2026
Q1 		$472 Buy
+21
New +$475 ﹤0.01% 4189

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Fifth Third Bancorp's EVMN Position: Q2 2026 in Review

Fifth Third Bancorp held its Evommune Inc (EVMN) position steady in Q2 2026 at 21 shares worth $273. The position accounts for ﹤0.01% of the portfolio, ranked #4276.

Fifth Third Bancorp first reported a position in EVMN in Q1 2026 and has held it in 2 quarters since. The position peaked at $472 in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Fifth Third Bancorp held 21 shares of Evommune Inc worth $273 as of Q2 2026.
  • Fifth Third Bancorp left its Evommune Inc share count unchanged in Q2 2026.
  • Evommune Inc made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4276 holding.
  • Fifth Third Bancorp first reported a position in Evommune Inc in Q1 2026 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Evommune Inc position peaked at $472 in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.